Authors: Chapel, HM Christie, JML Peach, V Chapman, RWG

Citation: Hm. Chapel et al., Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C, CLIN IMMUNO, 99(3), 2001, pp. 320-324

Authors: Jayaram, H Satsangi, J Chapman, RWG

Citation: H. Jayaram et al., Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?, GUT, 48(3), 2001, pp. 430-434

Authors: Satsangi, J Chapman, RWG Haldar, N Donaldson, P Mitchell, S Simmons, J Norris, S Marshall, SE Bell, JI Jewell, DP Welsh, KI

Citation: J. Satsangi et al., A functional polymorphism of the stromelysin gene (MMP3) influences susceptibility to primary sclerosing cholangitis, GASTROENTY, 121(1), 2001, pp. 124-130

Authors: Christie, JML Chapman, RWG

Citation: Jml. Christie et Rwg. Chapman, Combination therapy for chronic hepatitis C: interferon and ribavirin, HOSP MED, 60(5), 1999, pp. 357-361

Authors: Bate, CM Riley, SA Chapman, RWG Durnin, AT Taylor, MD

Citation: Cm. Bate et al., Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease, ALIM PHARM, 13(1), 1999, pp. 59-66